Beam Therapeutics Balance Sheet
NASDAQ: BEAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Beam Therapeutics financial position
At the end of fiscal 2025, Beam Therapeutics reported total assets of $1.48 billion, up 34.2% from a year earlier against total liabilities of $242.8 million. Shareholders' equity stood at $1.24 billion, or 83.6% of assets. The company held $294.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 13.09, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Beam Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 294.94M | 281.97M | 435.89M | 232.77M | 559.99M | 162.17M | 37.22M |
| Short-Term Investments | 950.27M | 568.77M | 753.98M | 845.37M | — | 137.50M | — |
| Total Current Assets | 1.27B | 878.15M | 1.21B | 1.09B | 1.27B | 308.32M | 94.54M |
| Property, Plant & Equipment | 104.50M | 111.41M | 124.96M | 115.62M | 84.26M | 38.51M | 24.29M |
| Long-Term Investments | — | — | — | — | — | 2.58M | — |
| Total Assets | 1.48B | 1.10B | 1.46B | 1.34B | 1.47B | 451.68M | 156.10M |
| Accounts Payable | 10.23M | 3.87M | 1.62M | 9.03M | 7.47M | 6.31M | 7.85M |
| Total Current Liabilities | 96.94M | 182.07M | 205.56M | 223.59M | 213.44M | 102.34M | 29.14M |
| Total Liabilities | 242.82M | 370.28M | 478.38M | 608.24M | 647.72M | 206.12M | 55.15M |
| Shareholders' Equity | 1.24B | 733.54M | 981.33M | 733.47M | 826.74M | 245.56M | -201.10M |
| Retained Earnings | -1.64B | -1.57B | -1.19B | -1.06B | -768.27M | -397.64M | -203.04M |
| Net Cash (Debt) | 1.25B | 850.74M | 1.19B | 1.08B | 559.99M | 299.67M | 37.22M |
| Shares Outstanding | 101.75M | 83.63M | 81.63M | 71.28M | 68.39M | 57.25M | 7.33M |
This table shows 7 annual periods of Beam Therapeutics's balance sheet, from FY 2025 back to FY 2019, across 13 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow BEAM's reporting calendar. What is a balance sheet?